To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

NCT07143929 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

CD7 Positive R/R PTCL

Interventions

DRUG: CAR-T

Sponsor

Peking University People's Hospital